medigraphic.com
ISSN 2007-932X (Electronic)
Órgano Oficial de Difusión de la Comisión Nacional de Arbitraje Médico

2020, Number 3

<< Back Next >>

Rev CONAMED 2020; 25 (3)

Potential drug interactions in outpatients in CONAMED medical complaint records

Garduño HJL

Language: Spanish
References: 19
Page: 115-122
PDF size: 126.69 Kb.


ABSTRACT

Introduction: Drug interactions are a type of medication error that can cause harm to the patient. These must be detected during the validation of the prescription and corrected by the professional in charge of the patient care. The purpose of this study was the identification, classification and prevalence of drugs interactions, as well as the medications involved in outpatient consultations of patients with a medical complaint file from the National Medical Arbitration Commission (CONAMED). Material and methods: A descriptive, retrospective and cross-sectional observational study was carried out. The outpatient consultation prescriptions of the medical complaint files registered from 2013 to 2016 in the CONAMED pharmacotherapy system were reviewed. Results: 1,995 consultations were analyzed in 170 medical records. Only 1,720 met the inclusion criteria. The number of medications per consultation for the female sex was 5.1 ± 3.5 (p ‹ 0.01). The average number of medications per consultation for patients ≥ 65 years was 6.4 ± 3.8 (p ‹ 0.01). The number of consultations with 5 or more medications (polypharmacy) in patients older than 65 or equal to 65 years was 305 (63.9%). The number of detected interactions according to severity were moderate 1415 (48.5%), higher 1,253 (43%), minor 193 (6.6%) and contraindicated 54 (1.9%), and according to their mechanism of action 46.8% correspond to pharmacodynamic interactions and 32.1% pharmacokinetics. The drugs most involved in the interactions are bezafibrate, pravastatin, captopril, metformin, acetylsalicylic acid, diclofenac, insulin and enalapril. Conclusion: Pharmacological interactions of a total of 8,282 medications prescribed in outpatient medical complaint records were analyzed. Pharmacological interactions occur more frequently in patients older than 65 years with polymedication and in the female gender. The majority are those that affect pharmacodynamics. The search for drug interactions with the use of softwares during the prescription should be carried out to improve treatment and patient safety.


REFERENCES

  1. Dirección General de Epidemiología. Anuario de morbilidad 1984-2019 [Base de datos en Internet]. [Consultado 11 de julio de 2020] Disponible en: http://www.epidemiologia.salud.gob.mx/anuario/html/anuarios.html

  2. Magro L, Moretti U, Leone R. Epidemiology and characteristics of adverse drug reactions caused by drugdrug interactions. Expert Opin Drug Saf. 2012; 11 (1): 83-94.

  3. López-Picazo JJ, Ruiz JC, Sánchez JF, Ariza A, Aguilera B, Lazaro D et al. Prevalence and typology of potential drug interactions occurring in primary care patients. Eur J Gen Pract. 2010; 16 (2): 92-99.

  4. Iniesta-Navalón C, Urbieta-Sanz E, Gascón-Cánovas JJ. Análisis de las interacciones medicamentosas asociadas a la farmacoterapia domiciliaria en pacientes ancianos hospitalizados. Rev Clin Esp. 2011; 211 (7): 344-351.

  5. Brewer L, Williams D. Clinically relevant drug-drug and drug-food interactions: underlying mechanisms and regulatory requirements for drug licensing. Pharmaceut Med. 2013; 27 (1): 9-23.

  6. Linares Borges A, Milián Vázquez PM, Jiménez Fernández L, Chala Tandrón JM, Alemán Aguilar H, Betancourt Rodríguez BY et al. Interacciones medicamentosas. Acta Farm Bonaerense. 2002; 21 (2): 139-148.

  7. Drug Interactions search - MICROMEDEX [Base de datos en Internet]. [consultado 24 de junio de 2020]. Disponible en: https://www.micromedexsolutions.com. [Se requiere suscripción para ver]

  8. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017; 17 (1): 230.

  9. Shah BM, Hajjar ER. Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin Geriatr Med. 2012; 28 (2): 173-186.

  10. Ahmed B, Nanji K, Mujeeb R, Patel MJ. Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study. PLoS One. 2014; 9 (11): e112133.

  11. Arce Tintaya A, Castro Luna RC. Caracterización de interacciones medicamentosas potenciales en las prescripciones médicas atendidas a pacientes ambulatorios [Tesis de Licenciatura]. Lima, Perú: Universidad WIENER; 2015.

  12. Oliván LMG, Hernández CC. Identificación e impacto clínico de las interacciones farmacológicas potenciales en prescripciones médicas del Hospital ISSSTE Pachuca, México. Rev Mex Ciencias Farm. 2006; 37 (4): 30-37.

  13. Chahin Ramez C. Interacciones medicamentosas en pacientes hospitalizados en el Servicio de Medicina Interna del Hospital Universitario “Dr. Ángel Larralde”: Junio 2014 - Diciembre 2015. Arch Venez Farmacol y Ter. 2016; 35 (1): 1-6.

  14. Carrasco ZD, Pérez CJ, López SAS, Meljem MJ. Modelo para el análisis de la farmacoterapia en expedientes clínico. Rev CONAMED. 2016; 21 (1): 4-15.

  15. Guía de Práctica Clínica de “Interacciones farmacológicas potenciales en la atención del adulto mayor”. México: Secretaría de Salud; 2010.

  16. Moya CR. Interacciones entre fármacos en una oficina de farmacia comunitaria. Ars Pharm. 2011; 52 (1): 16-22.

  17. Bellosta S, Corsini A. Statin drug interactions and related adverse reactions: an update. Expert Opin Drug Saf. 2018; 17 (1): 25-37.

  18. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest. 2002; 109 (10): 1321-1326.

  19. Coe LM, Denison JD, McCabe LR. Low dose aspirin therapy decreases blood glucose levels but does not prevent type I diabetes-induced bone loss. Cell Physiol Biochem. 2011; 28 (5): 923-932.




2020     |     www.medigraphic.com